IBBQ — INVESCO NASDAQ BIOTECH ETF
As of Q2 2026, 4 SEC-registered investment managers reported holding IBBQ (INVESCO NASDAQ BIOTECH ETF) in their latest 13F filings, with a combined reported value of $1.71M across 52.30K shares. That is -2.0% by share count (-1.06K shares) versus the previous quarter, while reported value moved +10.4%. Ownership is concentrated: the five largest holders account for 100.0% of reported value and the top ten for 100.0%.
Compared with the prior quarter, 1 opened new positions, 1 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| JPMorgan Chase & Co history | Q3 2021 | 238.78K | $6.11M | 0.00% | New |
| Citigroup Inc history | Q4 2021 | 100.00K | $2.37M | 0.00% | Reduce |
| Two Sigma Investments history | Q2 2026 | 51.40K | $1.68M | 0.00% | Hold |
| Citadel Advisors history | Q4 2024 | 10.71K | $230.46K | 0.00% | Reduce |
| UBS Group AG history | Q1 2026 | 1.33K | $38.44K | 0.00% | New |
| Bank of America Corp history | Q4 2025 | 870 | $24.70K | 0.00% | Reduce |
| Morgan Stanley history | Q2 2026 | 551 | $18.00K | 0.00% | Hold |
| Fidelity Management & Research (FMR) history | Q2 2026 | 263 | $8.59K | 0.00% | New |
| Wells Fargo & Co history | Q2 2026 | 85 | $2.78K | 0.00% | Hold |
New Positions (Q2 2026)
- Fidelity Management & Research (FMR) 263 sh · $8.59K
Fully Exited (vs previous quarter)
- UBS Group AG sold 1.33K sh · $38.44K
Fund Position History — shares by quarter (top 9 funds)
| Fund | Q3 2021 | Q4 2021 | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Two Sigma Investments | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 29.00K | 51.40K | 51.40K |
| Morgan Stanley | 350.00K | 50.00K | 1.06K | 1.06K | 1.06K | 1.00K | 1.00K | 1.00K | 1.00K | — | 501 | 1 | — | 2 | 3.06K | 1 | — | — | 551 | 551 |
| Fidelity Management & Research (FMR) | — | — | — | — | — | — | — | — | — | — | — | — | 1 | — | — | 1 | — | — | — | 263 |
| Wells Fargo & Co | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 85 | 85 |
| Bank of America Corp | 400.00K | 150.00K | 4.11K | 14.24K | 14.17K | 17.93K | 18.45K | 16.66K | 19.21K | 26.55K | 3.69K | 3.69K | 3.69K | 3.72K | 3.72K | 1.04K | 1.04K | 870 | — | — |
| UBS Group AG | — | 349 | 1.25K | 170 | — | 450 | — | 1.82K | 205 | — | — | — | 348 | — | 145 | — | 51 | — | 1.33K | — |
| Citadel Advisors | — | — | — | — | — | — | 15.34K | — | 18.55K | — | — | — | 13.28K | 10.71K | — | — | — | — | — | — |
| JPMorgan Chase & Co | 238.78K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Citigroup Inc | 400.00K | 100.00K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details